spacer
home > ict > autumn 2009 > equipped for success
PUBLICATIONS
International Clinical Trials

Equipped for Success

 

Over recent years, many good articles have been written about outsourcing in clinical studies. Most of these refer to outsourcing of trials by pharma companies to clinical research organisations, and cover all aspects from cost benefit analysis, supplier selection process, scorecards, performance measurement and management of customer and supplier relationships. At the risk of being inundated with responses from readers advising me to the contrary, I cannot recollect reading any articles regarding outsourcing of a company’s medical equipment requirements for clinical studies to a single supplier.

In many ways, this is understandable, as initiation of an outsourcing project is often instigated by senior levels within a business such as board members and directors. For the majority of clinical trials, the total cost of medical equipment is a very low figure, often less than two per cent of the trial cost. For this reason, medical equipment will rarely appear on senior management’s radar unless it has been the cause of serious delays or caused impairment of the results of a trial.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

David Maughan is Managing Director of Medical Equipment Supplies and Management Ltd (MESM), a global supplier of medical equipment to the clinical trials industry. David is also a non-executive director of the Optare Group (bus manufacturer), board member of the Northwest Industrial Development Board and also of the North-west Automotive Alliance. David spent 30 years working in the automotive sector in various procurement roles, the most recent being 10 years as Purchasing Director of Bentley motor cars, part of the VW Group. During that time he was a member of the corporate sourcing committee for all group purchases.

spacer
David Maughan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Three-tiered, mobile-app driven program tracks individuals’ physical and psychological symptoms from COVID-19

RALEIGH, N.C., March 20, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences announced today the commercial availability of the COVID-19 Monitoring Program, a mobile app-driven, tiered initiative that allows employers, payers, providers and health systems to track the health and wellbeing of individuals who may be asymptomatic, exposed or diagnosed with COVID-19 during the pandemic.
More info >>

White Papers

Considerations for Choosing the Right Wearable Drug Delivery System

West Pharmaceutical Services, Inc.

For patients with chronic conditions, the use of injectable biologic therapies is on the rise. Biologics, while providing considerable therapeutic benefit, can also present several challenges for both drug manufacturers and patients. In particular, many biologics are highly viscous and others require large doses to be injected slowly over time. This can make it difficult to deliver a consistent dose every time, potentially impacting medication adherence.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement